Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 36

1.

The impact of human papillomavirus vaccination on cervical cancer prevention efforts.

Massad LS, Einstein M, Myers E, Wheeler CM, Wentzensen N, Solomon D.

Gynecol Oncol. 2009 Aug;114(2):360-4. doi: 10.1016/j.ygyno.2009.04.005. Review.

3.

What is the role of HPV typing in the United States now and in the next five years in a vaccinated population?

Huh W, Einstein MH, Herzog TJ, Franco EL.

Gynecol Oncol. 2010 Jun;117(3):481-5. doi: 10.1016/j.ygyno.2010.01.037. Review.

PMID:
20417957
4.
5.

Cervical cancer prevention in the era of prophylactic vaccines: a preview for gynecologic oncologists.

Society of Gynecologic Oncologists Education Resource Panel Writing group., Collins Y, Einstein MH, Gostout BS, Herzog TJ, Massad LS, Rader JS, Wright J.

Gynecol Oncol. 2006 Sep;102(3):552-62. Review.

PMID:
16979432
6.

Age-appropriate use of human papillomavirus vaccines in the U.S.

Castle PE, Fetterman B, Akhtar I, Husain M, Gold MA, Guido R, Glass AG, Kinney W.

Gynecol Oncol. 2009 Aug;114(2):365-9. doi: 10.1016/j.ygyno.2009.04.035. Review.

7.

Cervical cancer: screening and prevention.

Behtash N, Mehrdad N.

Asian Pac J Cancer Prev. 2006 Oct-Dec;7(4):683-6. Review.

8.

How does public policy impact cervical screening and vaccination strategies?

Herzog TJ, Huh WK, Einstein MH.

Gynecol Oncol. 2010 Nov;119(2):175-80. doi: 10.1016/j.ygyno.2010.08.021. Review.

10.

Human papillomavirus vaccines: current status and future prospects.

Garland SM, Smith JS.

Drugs. 2010 Jun 18;70(9):1079-98. doi: 10.2165/10898580-000000000-00000. Review.

PMID:
20518577
11.

HPV and cervical cancer: screening or vaccination?

Bosch FX, Castellsagué X, de Sanjosé S.

Br J Cancer. 2008 Jan 15;98(1):15-21. doi: 10.1038/sj.bjc.6604146. Review.

12.

Human papilloma virus (HPV) prophylactic vaccination: challenges for public health and implications for screening.

Adams M, Jasani B, Fiander A.

Vaccine. 2007 Apr 20;25(16):3007-13. Review.

PMID:
17292517
13.

Modern screening in cervical cancer. Perspectives of HPV prophylactic vaccines.

Vlădăreanu R, Andrei C.

Rev Med Chir Soc Med Nat Iasi. 2007 Jan-Mar;111(1):144-54. Review.

PMID:
17595860
14.

Chapter 30: HPV vaccines and screening in the prevention of cervical cancer; conclusions from a 2006 workshop of international experts.

Wright TC, Bosch FX, Franco EL, Cuzick J, Schiller JT, Garnett GP, Meheus A.

Vaccine. 2006 Aug 31;24 Suppl 3:S3/251-61. Review.

PMID:
16950014
15.

Human papillomavirus vaccines versus cervical cancer screening.

Stanley M.

Clin Oncol (R Coll Radiol). 2008 Aug;20(6):388-94. doi: 10.1016/j.clon.2008.04.006. Review.

PMID:
18538554
16.

AS04-adjuvanted human papillomavirus-16/18 vaccination: recent advances in cervical cancer prevention.

Schwarz TF.

Expert Rev Vaccines. 2008 Dec;7(10):1465-73. doi: 10.1586/14760584.7.10.1465. Review.

PMID:
19053203
17.

Overcoming the barriers to HPV vaccination in high-risk populations in the US.

Downs LS Jr, Scarinci I, Einstein MH, Collins Y, Flowers L.

Gynecol Oncol. 2010 Jun;117(3):486-90. doi: 10.1016/j.ygyno.2010.02.011. Review.

PMID:
20303156
18.

Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer.

Arbyn M, Ronco G, Anttila A, Meijer CJ, Poljak M, Ogilvie G, Koliopoulos G, Naucler P, Sankaranarayanan R, Peto J.

Vaccine. 2012 Nov 20;30 Suppl 5:F88-99. doi: 10.1016/j.vaccine.2012.06.095. Review. Erratum in: Vaccine. 2013 Dec 16;31(52):6266.

PMID:
23199969
19.

A public health approach to cervical cancer control: considerations of screening and vaccination strategies.

Goldie S.

Int J Gynaecol Obstet. 2006 Nov;94 Suppl 1:S95-105. Review.

PMID:
17276172
20.
Items per page

Supplemental Content

Support Center